Engineering biology is recognised as one of the UK’s critical technologies within the Industrial Strategy, with the potential to drive economic growth, strengthen supply chain resilience and create high-value jobs across the country.

CPI is helping to turn this ambition into reality by working with businesses of all sizes to accelerate the development, scale-up and commercialisation of engineering biology innovations. Through our specialist expertise, pilot-scale facilities and collaborative programmes, we help organisations reduce technical risk, attract investment and bring new products and processes to market faster.

Our capabilities span the full innovation journey, from strain engineering and bioprocess development through to downstream processing, engineering design, modelling and industrial scale-up. This enables companies to translate cutting-edge research into commercially viable manufacturing across sectors including healthcare, food, chemicals, advanced materials and sustainable manufacturing.

By supporting businesses to adopt engineering biology at scale, CPI is helping to strengthen UK manufacturing capability, attract inward investment and build the industries that will deliver long-term economic growth, improved productivity and a more sustainable future.